Verona Pharma plc buy Wolfe Research
Start price
01.07.25
/
50%
€0.51
Target price
01.07.26
€144.28
Performance (%)
-
End price
02.07.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Wolfe_Research for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

